Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep 28;107(10):e4259-e4260.
doi: 10.1210/clinem/dgac301.

Potential Role of Ultrafast-acting Insulin Analogues in the Treatment of Diabetic Ketoacidosis

Affiliations
Comment

Potential Role of Ultrafast-acting Insulin Analogues in the Treatment of Diabetic Ketoacidosis

Theocharis Koufakis et al. J Clin Endocrinol Metab. .
No abstract available

Keywords: diabetic ketoacidosis; insulin; ultrafast-acting insulin analogues.

PubMed Disclaimer

Comment on

References

    1. Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020;6(1):40. - PubMed
    1. Vincent M, Nobécourt E. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies. Diabetes Metab. 2013;39(4):299-305. - PubMed
    1. Ramaesh A. Incidence and long-term outcomes of adult patients with diabetic ketoacidosis admitted to intensive care: a retrospective cohort study. J Intensive Care Soc. 2016;17(3):222-233. - PMC - PubMed
    1. Rao P, Jiang SF, Kipnis P, et al. . Evaluation of outcomes following hospital-wide implementation of a subcutaneous insulin protocol for diabetic ketoacidosis. JAMA Netw Open. 2022;5(4):e226417. - PMC - PubMed
    1. Umpierrez GE, Latif K, Stoever J, et al. . Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004;117(5):291-296. - PubMed

MeSH terms